glp-1 analogue semaglutide PDB-101: Molecule of the Month: Receptor Agonists GLP-1 Receptor Agonists as Treatments

We need to design it: Messaging frameworks that help patients reframe weight stability as a success, not just weight loss Provider scripts that normalize shifts in hunger and offer non-pharmacologic strategies Peer support groups that address not just logistics but identity transition Because the goal isnt to maintain the number on the scale

Treatment should continue only if there is a clinically meaningful response (for example, HbA1c reduction 11 mmol/mol and weight loss 3% at around 6 months)

Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association

This clean-label approach supports flexibility and simplicity

They may contain different fillers, dosages, or inactive ingredients